Topic specific news, updated constantly
from the most reliable sources, all in one place.
Other NewsOnly
Information Pages
Information Pages
Latest health news: The lavender pill that can calm your nerves and an instant ... - Daily Mail
 Daily Mail | Latest health news: The lavender pill that can calm your nerves and an instant ... Daily Mail By Daily Mail Reporter In an Austrian study, over 75 per cent of patients given the treatment showed improvement, compared with just half of those on a ... |
Whoopi Goldberg takes a bite of Hell`s Kitchen cusine - Monsters and Critics.com
 Monsters and Critics.com | Whoopi Goldberg takes a bite of Hell`s Kitchen cusine Monsters and Critics.com Padma Lakshmi co-hosts the First Annual Blossom Ball to benefit the Foundation of America, held at The Prince George Ballroom, NYC. ... |
Neurocrine Looks Well Positioned - Zacks.com
Neurocrine Looks Well Positioned Zacks.com The drug is also used by Ob/Gyns for the treatment of and uterine fibroids, as well as to treat precocious puberty, and to control ovarian ... |
Abbott 2Q profit flat on charges - Chicago Breaking Business - Tribune
 RTT News | Abbott 2Q profit flat on charges Chicago Breaking Business - Tribune Excluding special items like an after-tax charge of $75 million for in-process research and development of an experimental treatment, ... Abbott's 2nd-quarter earnings flat |
The golden anniversary of birth control pills - Carolina Weekly
The golden anniversary of birth control pills Carolina Weekly Taking a constant dose of hormones has been in practice, particularly for patients with migraine headaches and , since at least the '80s ... |
BUYINS.NET: QCOR, UAM, OFIX, NBIX, MSA, TYL Expected To Be Higher After ... - Trading Markets (press release)
BUYINS.NET: QCOR, UAM, OFIX, NBIX, MSA, TYL Expected To Be Higher After ... Trading Markets (press release) Its products in clinical development include Elagolix, a phase II product for ; CRF1 Antagonist, a phase II product for mood disorders; ... |
Repros Therapeutics Receives Investigational Review Board Approval to Commence ... - MarketWatch (press release)
Repros Therapeutics Receives Investigational Review Board Approval to Commence ... MarketWatch (press release) In previous studies a 12.5 mg dose was well tolerated and yielded statistically significant efficacy signals for both uterine fibroids and . ... Repros begins Proellex study, shares spike |
ASK THE EXPERT: Uterine fibroid tumors - Daily Breeze
ASK THE EXPERT: Uterine fibroid tumors Daily Breeze Fibroid tumors are non-cancerous growths of muscle and connective tissue in the uterus (sometimes accompanied by , which is tissue outside the ... |
Health news: A pill to treat , protecting your arteries with ... - Daily Mail
 Daily Mail | Health news: A pill to treat endometriosis, protecting your arteries with ... Daily Mail is a condition where cells that usually line the womb are found elsewhere in the body, such as in the ovaries. These cells behave in the same ... |
5 Million Women in the US Suffer from - PR Web (press release)
5 Million Women in the US Suffer from Endometriosis PR Web (press release) Our network of clinics treats twice as many patients than the national average for those whose primary infertility diagnosis is . ... IntegraMed(R) Q2 Net Income Rose 45% to $1.6M, Adjusted EBITDA Increased 23 ... IntegraMed® Q2 Net Income Rose 45% to $1.6M, Adjusted EBITDA Increased 23% to ... |